mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |